• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

VIDEO: Aimee Tharaldson, PharmD, Discusses the Impact of Biosimilars on the Specialty Pharmacy Market

Article

In this video, Aimee Tharaldson, PharmD, Senior Clinical Consultant, Emerging Therapeutics Express Scripts, Inc, talks about the impact that biosimilar medications could potentially have on the specialty pharmacy market.

In this video, Aimee Tharaldson, PharmD, Senior Clinical Consultant, Emerging Therapeutics Express Scripts, Inc, talks about the impact that biosimilar medications could potentially have on the specialty pharmacy market.

Although Dr. Tharaldson says that there has not been an impact yet, she says that "eventually, once more guidance is available, we will see more of the true biosimilars approved. Once we can get these to be interchangable at the point of service -- that's where we're going to see a lot of cost savings."

This video was taken on Thursday, October 4, 2012, at the Academy of Managed Care Pharmacy's 2012 Educational Conference in Cincinnati, OH.

Related Videos
Bevey Miner, executive vice president of health care strategy and policy, Consensus Cloud Solutions
dr parth rali
dr kimberly maxfield
dr april armstrong
Amal Trivedi, MD
Dr. Jorge Garcia
Amitkumar Mehta, MD
Edward Arrowsmith, MD, MPH
Related Content
© 2023 MJH Life Sciences
AJMC®
All rights reserved.